6197-31-5Relevant academic research and scientific papers
FATTY ACID AMIDES WITH A CYSTEAMINE OR AN ACETYLATED CYSTEAMINE GROUP AND USES THEREOF
-
Paragraph 00124; 00125; 00126, (2014/04/04)
The disclosure herein provides a compound of formula 1, 2 and 3 or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, transdermal administration, or injection. Such compositions may be used to treatment of metabolic condition, cystinosis, non-alcoholic Steatohepatitis, hypertriglyceridemia or neurodegenerative disorders or its associated complications.
Compound, composition and uses thereof
-
Page/Page column 23, (2013/05/23)
The disclosure herein provides the compounds of Formulas 1, 2 and 3 and their pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, transdermal administration, and/or injection. Such compositions may be used for the treatment of metabolic conditions, cystinosis, non-alcoholic Steatohepatitis, hypertriglyceridemia, and/or neurodegenerative disorders, and/or their associated complications.
